Strumento inattivo

Altre lingue Cosmo Pharmaceuticals S.p.A Swiss Exchange

Azioni

IT0004167463

Prezzo di chiusura Swiss Exchange Altri mercati azionari
- ^CHF	-

26/04	Cosmo Pharmaceuticals N.V. annuncia cambiamenti esecutivi in occasione della prossima Assemblea Generale Annuale del 24 maggio 2024	CI
25/04	Cosmo Pharmaceuticals nomina un nuovo amministratore delegato, presidente	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Written Proxy	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Proposed Amendments to the Renumeration Policy	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Notification of number of shares as of 6 June 2024	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Explanatory Notes	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Convening Notice	06/06
Cosmo Pharmaceuticals N : Written proxy – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Proposed Amendments to the Remuneration Policy – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Notification of number of shares 6 June 2024 – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Explanatory notes – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Convening notice – EGM 5 July 2024	06/06
Morning Briefing - Markt Schweiz	03/06
Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down	03/06
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX	03/06
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024	01/06
Cosmo Pharmaceuticals N : reports excellent final Full Year 2023 financial results – Increases operating profit guidance for 2024 – Dividend of € 2.00 per share will be proposed at EGM on 5 July 2024	31/05
Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting	24/05
Cosmo Pharmaceuticals N : ’ Shareholders approve all Agenda Items at Annual General Meeting	24/05
Cosmo Pharmaceuticals N : Niall Donnelly CV	09/05
Cosmo Pharmaceuticals N : Convening notice	09/05
Cosmo Pharmaceuticals N : Written Proxy	09/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cosmo Pharmaceuticals S.p.A Swiss Exchange

Azioni

IT0004167463

Altre lingue

Filtri